A Partially Multiplexed HIV Drug Resistance (HIVDR) Assay for Monitoring HIVDR Mutations of the Protease, Reverse-Transcriptase (PRRT), and Integrase (INT)

Author:

DeVos Joshua1ORCID,McCarthy Kimberly2,Sewe Victor3,Akinyi Grace3,Junghae Muthoni2,Opollo Valarie3,Nouhin Janin4,Shafer Robert4,Zeh Clement1,Ramos Artur1,Alexander Heather1,Chang Joy1

Affiliation:

1. International Laboratory Branch, Division of Global HIV and Tuberculosis (TB), Center for Global Health, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA

2. CDC Kenya, Nairobi, Kenya

3. HIV Research Laboratory, Kenya Medical Research Institute-Center for Global Health Research, Kisumu, Kenya

4. Stanford University, Stanford, California, USA

Abstract

This HIVDR genotyping assay works for both plasma and DBS samples, requires low sample input, and is sensitive. This assay has the potential to be a user-friendly and cost-effective HIVDR assay because of its partially multiplexed design. Application of this genotyping assay will help HIVDR monitoring in HIV high-burdened countries using a DGT-based HIV drug regimen recommended by the U.S. President's Emergency Plan for AIDS Relief and the WHO.

Funder

U.S. President's Emergency Plan for AIDS Relief

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Reference28 articles.

1. UNAIDS. 2014. 90–90-90 An ambitious treatment target to help end the AIDS epidemic. https://www.unaids.org/sites/default/files/media_asset/90-90-90_en.pdf.

2. UNAIDS. 2014. Fast-Track - Ending the AIDS epidemic by 2030. https://www.unaids.org/en/resources/documents/2014/JC2686_WAD2014report.

3. UNAIDS. 2020. Global HIV & AIDS statistics - 2020 fact sheet. https://www.unaids.org/en/resources/fact-sheet.

4. WHO. 2017. HIV drug resistance report 2017. https://www.who.int/publications/i/item/9789241512831.

5. WHO. 2019. HIV drug resistance report 2019. https://www.who.int/publications/i/item/WHO-CDS-HIV-19.21.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3